By screening people for eating disorders and disordered eating before these medications are prescribed, we can prevent ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

With GLP-1 weight loss comes muscle loss. Gyms and personal trainers are rising to the challenge to help people build it back ...

SAN DIEGO -- Two retrospective studies hinted at potential negative effects of GLP-1 receptor agonists for patients requiring ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

SGLT2 inhibitors and GLP-1RAs yielded lower risks for COPD exacerbation than DPP-4 inhibitors among patients with type 2 diabetes.

With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...

Consumers taking GLP-1 drugs like Ozempic will need to adapt their shopping habits and diets, opening opportunities for food ...

And of course, lawsuits are being filed left and right. In theory, the FDA’s removal of GLP-1s from its shortage list should mean any patient who needs the brand-name drugs will be able to get them.

He requires clients on GLP-1 drugs to get body scans every two to four weeks. “It’s so we’re not just guessing. We’re feeling good, but what does that mean, data-wise? We’re looking to ...

Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...

The cohorts were propensity score matched on the basis of baseline demographic characteristics, comorbidities, and use of medication, resulting in 61,057 patients receiving GLP-1 RAs (mean age ...